Maltotriose-modified poly(propylene imine) Glycodendrimers as a potential novel platform in the treatment of chronic lymphocytic Leukemia. A proof-of-concept pilot study in the animal model of CLL

Autor: Franiak-Pietryga, Ida, Ziemba, Barbara, Sikorska, Hanna, Jander, Magdalena, Kuncman, Wojciech, Danilewicz, Marian, Appelhans, Dietmar, Lewkowicz, Przemyslaw, Ostrowska, Kinga, Bryszewska, Maria, Borowiec, Maciej
Zdroj: In Toxicology and Applied Pharmacology 15 September 2020 403
Databáze: ScienceDirect
Externí odkaz: